中基長壽科學(00767.HK):聯交所將暫停公司股份買賣 將轉交上市委員會複核
格隆匯12月20日丨中基長壽科學(00767.HK)發佈公吿,2021年12月17日,聯交所就其所作決定向公司發出函件,當中表示公司未能維持上市規則第13.24條所要求的足夠業務運作以保證其股份可繼續上市,並將根據上市規則第6.01(3)條暫停公司股份買賣。
據該函件所述,公司須重新符合上市規則第13.24條的規定,並履行聯交所可能制定的任何復牌指引及全面遵守上市規則且獲聯交所信納後,方可恢復公司股份買賣。根據上市規則第6.01A(1)條,倘連續18個月暫停買賣,聯交所或會撤銷公司股份的上市地位。根據上市規則第2B章,公司有權將該決定轉交上市委員會複核。任何複核要求必須於該決定之日期起計七個營業日內(即2021年12月29日或之前)送達上市委員會祕書處。除非公司申請複核該決定,否則公司股份將於該決定之日期起計滿七個營業日後(即2021年12月30日)暫停買賣。
公司已決定於2021年12月29日或之前提出要求將該決定轉交上市委員會複核,公司正在編制有關要求函件。因此,提出複核該決定的要求後,公司股份將繼續買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.